Cargando…
A Soluble Activin Receptor Type IIB Does Not Improve Blood Glucose in Streptozotocin-Treated Mice
Type 1 diabetes mellitus (T1DM), or insulin dependent DM, is accompanied by decreased muscle mass. The growth factor myostatin (MSTN) is a negative regulator of muscle growth, and a loss of MSTN signaling has been shown to increase muscle mass and prevent the development of obesity, insulin resistan...
Autores principales: | Wang, Qian, Guo, Tingqing, Portas, Jennifer, McPherron, Alexandra C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279095/ https://www.ncbi.nlm.nih.gov/pubmed/25561902 http://dx.doi.org/10.7150/ijbs.10430 |
Ejemplares similares
-
Inhibition of myostatin signaling increases glucose in insulin-deficient diabetic mice
por: Wang, Qian, et al.
Publicado: (2012) -
Myostatin Inhibition in Muscle, but Not Adipose Tissue, Decreases Fat Mass and Improves Insulin Sensitivity
por: Guo, Tingqing, et al.
Publicado: (2009) -
Myostatin Inhibition Prevents Diabetes and Hyperphagia in a Mouse Model of Lipodystrophy
por: Guo, Tingqing, et al.
Publicado: (2012) -
Myostatin inhibition improves hyperglycemia and hyperphagia in lipodystrophic mice
por: Guo, Tingqing, et al.
Publicado: (2012) -
Increasing muscle mass to improve metabolism
por: McPherron, Alexandra C., et al.
Publicado: (2013)